Exploratory secondary analysis of the ASPREE trial (610 healthy adults aged 70+): daily aspirin 100 mg did not change total or periventricular white matter hyperintensity or retinal vessel calibre vs placebo over 3 years, but deep WMH rose more (β 0.14).
Secondary analysisn = 610
Abhayaratna et al. The effects of daily low-dose aspirin on white matter hyperintensity lesions and retinal vascular calibre in healthy older adults: the ENVIS-ion exploratory neuroimaging substudy of the ASPREE randomised clinical trial